Those aspiring to outpace the market meticulously engage in the process of selecting individual stocks. Strategic choices can be instrumental in accelerating your wealth.
As of close of business last night, Zentalis Pharmaceuticals Inc’s stock clocked out at $2.22, down -3.48% from its previous closing price of $2.30. In other words, the price has decreased by -$3.48 from its previous closing price. On the day, 2.47 million shares were traded. ZNTL stock price reached its highest trading level at $2.41 during the session, while it also had its lowest trading level at $2.2088.
Ratios:
To gain a deeper understanding of ZNTL’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 7.29 and its Current Ratio is at 7.29. In the meantime, Its Debt-to-Equity ratio is 0.12 whereas as Long-Term Debt/Eq ratio is at 0.11.
On June 20, 2024, UBS Downgraded its rating to Neutral which previously was Buy and also lowered its target price recommendation from $28 to $5.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Jan 02 ’25 when Lackner Mark sold 4,411 shares for $3.12 per share. The transaction valued at 13,762 led to the insider holds 191,317 shares of the business.
Diana Hausman bought 9,888 shares of ZNTL for $28,294 on Oct 31 ’24. On Oct 04 ’24, another insider, Vultaggio Vincent, who serves as the Principal Accounting Officer of the company, sold 1,603 shares for $3.18 each. As a result, the insider received 5,098 and left with 33,855 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ZNTL now has a Market Capitalization of 158209184 and an Enterprise Value of -189776816. For the stock, the TTM Price-to-Sale (P/S) ratio is 3.90 while its Price-to-Book (P/B) ratio in mrq is 0.45. Its current Enterprise Value per Revenue stands at -4.679 whereas that against EBITDA is 0.913.
Stock Price History:
The Beta on a monthly basis for ZNTL is 1.80, which has changed by -0.831307 over the last 52 weeks, in comparison to a change of 0.23809385 over the same period for the S&P500. Over the past 52 weeks, ZNTL has reached a high of $18.07, while it has fallen to a 52-week low of $2.13. The 50-Day Moving Average of the stock is -29.13%, while the 200-Day Moving Average is calculated to be -59.43%.
Shares Statistics:
It appears that ZNTL traded 1.49M shares on average per day over the past three months and 2496380 shares per day over the past ten days. A total of 71.15M shares are outstanding, with a floating share count of 55.11M. Insiders hold about 20.57% of the company’s shares, while institutions hold 83.21% stake in the company. Shares short for ZNTL as of 1735603200 were 4543953 with a Short Ratio of 3.06, compared to 1732838400 on 4669830. Therefore, it implies a Short% of Shares Outstanding of 4543953 and a Short% of Float of 12.839999999999998.
